Showing results (2591-2600 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|November 18, 2024
Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancerEfstratios Koutroumpakis, Neha Venkatesh, Ana Aparicio, et al.
The Oncologist|October 29, 2024
Clinical value of comprehensive genomic profiling on clinical trial enrollment for patients with advanced solid tumorsRichard S P Huang, Jessica K Lee, Katherine T Lofgren
The Oncologist|October 29, 2024
Therapeutic targeting of the protein tyrosine kinase-7 in cancer: an overviewKim Mottard, Julie Cokaiko, Bernard Rogister, et al.
The Oncologist|October 29, 2024
Long-term safety of selpercatinib for Rearranged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over timeLuis E Raez, Ashish C Massey, Scott S Barker, et al.
The Oncologist|August 9, 2024
Social supports in patients with cancer attending an Irish cancer center: a cross-sectional studyCaitriona Goggin, Yasser Ged, Dara Bracken-Clarke, et al.
The Oncologist|August 13, 2024
Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomesMichael T Wotman, Tara Ivic-Pavlicic, William H Westra, et al.
The Oncologist|July 18, 2024
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinomaGregory P Botta, Maen Abdelrahim, Ronald L Drengler, et al.
The Oncologist|July 10, 2024
Model-informed drug development of envafolimab, a subcutaneously injectable PD-L1 antibody, in patients with advanced solid tumorsCheng Cui, Jing Wang, Chunyang Wang, et al.
The Oncologist|July 10, 2024
FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinomaShaoqing Liu, Jialei Weng, Manqing Cao, et al.
The Oncologist|July 10, 2024
Optimal patient selection for yttrium-90 glass plus chemotherapy in the treatment of colorectal liver metastases: additional quality of life, efficacy, and safety analyses from the EPOCH studyRiad Salem, Etienne Garin, Eveline Boucher, et al.
Pageof 571